- Tytuł:
- Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403).
- Autorzy:
- Temat:
-
CLINICAL drug trials
LUNG cancer
EPIDERMAL growth factorDRUG therapy
TOXICITY testing
GENETIC mutation - Źródło:
- British Journal of Cancer; 3/4/2008, Vol. 98 Issue 5, p907-914, 8p, 7 Charts, 1 Graph
Czasopismo naukowe